Correlation Between Definitive Healthcare and Clearpoint Neuro

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Definitive Healthcare and Clearpoint Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Definitive Healthcare and Clearpoint Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Definitive Healthcare Corp and Clearpoint Neuro, you can compare the effects of market volatilities on Definitive Healthcare and Clearpoint Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Definitive Healthcare with a short position of Clearpoint Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Definitive Healthcare and Clearpoint Neuro.

Diversification Opportunities for Definitive Healthcare and Clearpoint Neuro

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Definitive and Clearpoint is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Definitive Healthcare Corp and Clearpoint Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clearpoint Neuro and Definitive Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Definitive Healthcare Corp are associated (or correlated) with Clearpoint Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clearpoint Neuro has no effect on the direction of Definitive Healthcare i.e., Definitive Healthcare and Clearpoint Neuro go up and down completely randomly.

Pair Corralation between Definitive Healthcare and Clearpoint Neuro

Allowing for the 90-day total investment horizon Definitive Healthcare Corp is expected to under-perform the Clearpoint Neuro. But the stock apears to be less risky and, when comparing its historical volatility, Definitive Healthcare Corp is 2.77 times less risky than Clearpoint Neuro. The stock trades about -0.29 of its potential returns per unit of risk. The Clearpoint Neuro is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest  1,196  in Clearpoint Neuro on September 27, 2024 and sell it today you would earn a total of  375.00  from holding Clearpoint Neuro or generate 31.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Definitive Healthcare Corp  vs.  Clearpoint Neuro

 Performance 
       Timeline  
Definitive Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Definitive Healthcare Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong technical indicators, Definitive Healthcare is not utilizing all of its potentials. The newest stock price confusion, may contribute to short-horizon losses for the traders.
Clearpoint Neuro 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Clearpoint Neuro are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Clearpoint Neuro unveiled solid returns over the last few months and may actually be approaching a breakup point.

Definitive Healthcare and Clearpoint Neuro Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Definitive Healthcare and Clearpoint Neuro

The main advantage of trading using opposite Definitive Healthcare and Clearpoint Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Definitive Healthcare position performs unexpectedly, Clearpoint Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clearpoint Neuro will offset losses from the drop in Clearpoint Neuro's long position.
The idea behind Definitive Healthcare Corp and Clearpoint Neuro pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets